GlaxoSmithKline misinterpreted crucial details of a study finding that Avandia, its blockbuster diabetes drug, is safe, a medical reviewer for the Food and Drug Administration said Friday. Correctly interpreted, the study actually supports critics’ contentions that Avandia may cause heart attacks, said the reviewer, Dr. Thomas Marciniak, in a posting on the F.D.A.’s Web site. The company’s misreadings of the study, [...]
Continue reading...Saturday, February 20, 2010
The diabetes drug Avandia produced by GlaxoSmithKline is linked with tens of thousands of heart attacks, and drugmaker GlaxoSmithKline knew of the risks for years but worked to keep them from the public, according to a Senate committee report released on 20., February of 2010. The senate report by the Senate Finance Committee also criticized the FDA, [...]
Continue reading...Sunday, July 27, 2008
Avandia (rosiglitazone maleate) is a popular diabetes drug made by GlaxoSmithKline. A recent study by the FDA has lead to nationwide Avandia recall as the tablets have been shown to cause serious side effects including an increased risk of heart attack and cardiovascular diseases.
Continue reading...
Saturday, July 10, 2010
0 Comments